Predicting the Activity of Oral Lichen Planus with Glycolysis-related Molecules: A Scikit-learn-based Function

Abstract

Objective

Oral lichen planus (OLP) is one of the most common oral mucosa diseases, and is mainly mediated by T lymphocytes. The metabolic reprogramming of activated T cells has been shown to transform from oxidative phosphorylation to aerobic glycolysis. The present study investigated the serum levels of glycolysis-related molecules (lactate dehydrogenase, LDH; pyruvic acid, PA; lactic acid, LAC) in OLP, and the correlation with OLP activity was assessed using the reticular, atrophic and erosive lesion (RAE) scoring system.

Methods

Univariate and multivariate linear regression functions based on scikit-learn were designed to predict the RAE scores in OLP patients, and the performance of these two machine learning functions was compared.

Results

The results revealed that the serum levels of PA and LAC were upregulated in erosive OLP (EOLP) patients, when compared to healthy volunteers. Furthermore, the LDH and LAC levels were significantly higher in the EOLP group than in the nonerosive OLP (NEOLP) group. All glycolysis-related molecules were positively correlated to the RAE scores. Among these, LAC had a strong correlation. The univariate function that involved the LAC level and the multivariate function that involved all glycolysis-related molecules presented comparable prediction accuracy and stability, but the latter was more time-consuming.

Conclusion

It can be concluded that the serum LAC level can be a user-friendly biomarker to monitor the OLP activity, based on the univariate function developed in the present study. The intervention of the glycolytic pathway may provide a potential therapeutic strategy.

References

[1] Society of Oral MedicineChinese Stomatological Association. Guideline for the diagnosis and treatment of oral lichen planus (revision). Zhonghua Kou Qiang Yi Xue Za Zhi (Chinese), 2022, 57(2): 115-121

[2] van der MeijEH, MastH, van der WaalI. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol, 2007, 43(8): 742-748

[3] ZhouG, ZhangJ, RenXW, et al.. Increased B7-H1 expression on peripheral blood T cells in oral lichen planus correlated with disease severity. J Clin Immunol, 2012, 32(4): 794-801

[4] HuJY, ZhangJ, CuiJL, et al.. Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus. Cytokine, 2013, 62(1): 141-145

[5] HuJY, ZhangJ, MaJZ, et al.. MicroRNA-155-IFN-gamma Feedback Loop in CD4(+)T Cells of Erosive type Oral Lichen Planus. Sci Rep, 2015, 5: 16935

[6] LuR, ZhouG, DuG, et al.. Expression of T-bet and GATA-3 in peripheral blood mononuclear cells of patients with oral lichen planus. Arch Oral Biol, 2011, 56(5): 499-505

[7] XieS, DingL, XiongZ, et al.. Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. J Huazhong Univ Sci Tech Med Sci, 2012, 32(3): 451-457

[8] VignaliDA, CollisonLW, WorkmanCJ. How regulatory T cells work. Nat Rev Immunol, 2008, 8(7): 523-532

[9] ZhouL, CaoT, WangY, et al.. Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus. Inflammation, 2016, 39(3): 1205-1215

[10] DumitruC, KabatAM, MaloyKJ. Metabolic Adaptations of CD4(+) T Cells in Inflammatory Disease. Front Immunol, 2018, 9: 540

[11] BantugGR, GalluzziL, KroemerG, et al.. The spectrum of T cell metabolism in health and disease. Nat Rev Immunol, 2018, 18(1): 19-34

[12] GerrietsVA, KishtonRJ, JohnsonMO, et al.. Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression. Nat Immunol, 2016, 17(12): 1459-1466

[13] ChenX, LinH, YangD, et al.. Early-life undernutrition reprograms CD4(+) T-cell glycolysis and epigenetics to facilitate asthma. J Allergy Clin Immunol, 2019, 143(6): 2038-2051.e12

[14] MichalekRD, GerrietsVA, JacobsSR, et al.. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol, 2011, 186(6): 3299-3303

[15] Palsson-McDermottEM, O’NeillLA. The Warburg effect then and now: from cancer to inflammatory diseases. Bioessays, 2013, 35(11): 965-973

[16] WarburgO, WindF, NegeleinE. The Metabolism of Tumors in the Body. J Gen Physiol, 1927, 8(6): 519-530

[17] GristJT, JarvisLB, GeorgievaZ, et al.. Extracellular Lactate: A Novel Measure of T Cell Proliferation. J Immunol, 2018, 200(3): 1220-1226

[18] ShanbehzadehM, AfrashMR, MiraniN, et al.. Comparing machine learning algorithms to predict 5-year survival in patients with chronic myeloid leukemia. BMC Med Inform Decis Mak, 2022, 22(1): 236

[19] ZhangG, ShiY, YinP, et al.. A machine learning model based on ultrasound image features to assess the risk of sentinel lymph node metastasis in breast cancer patients: Applications of scikit-learn and SHAP. Front Oncol, 2022, 12: 944569

[20] CantoAM, MullerH, FreitasRR, et al.. Oral lichen planus (OLP): clinical and complementary diagnosis. An Bras Dermatol, 2010, 85(5): 669-675

[21] González-MolesM, Ruiz-ÁvilaI, González-RuizL, et al.. Malignant transformation risk of oral lichen planus: A systematic review and comprehensive meta-analysis. Oral Oncol, 2019, 96: 121-130

[22] JäwertF, NymanJ, OlssonE, et al.. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer. Oral Oncol, 2021, 121: 105469

[23] YinJ, YangX, ZengQ, et al.. The positive correlation of the CCL2-CCR2 axis with the disease activity may indicate the fundamental role in the pathogenesis of oral lichen planus. J Oral Pathol Med, 2016, 45(1): 41-47

[24] ZhuZD, RenXM, ZhouMM, et al.. Salivary cytokine profile in patients with oral lichen planus. J Dent Sci, 2022, 17(1): 100-105

[25] AghbariSMH, GaafarSM, ShakerOG, et al.. Evaluating the accuracy of microRNA27b and microRNA137 as biomarkers of activity and potential malignant transformation in oral lichen planus patients. Arch Dermatol Res, 2018, 310(3): 209-220

[26] CertoM, TsaiCH, PucinoV, et al.. Lactate modulation of immune responses in inflammatory versus tumour microenvironments. Nat Rev Immunol, 2021, 21(3): 151-161

[27] GuptaGS. The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients. Inflammation, 2022, 45(6): 2091-2123

[28] WangF, ZhangJ, ZhouG. The mTOR-glycolytic pathway promotes T-cell immunobiology in oral lichen planus. Immunobiology, 2020, 225(3): 151933

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology